U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 29

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr5:149460567-149460568
GRCh38:
Chr5:150081004-150081005
CSF1RE24fsBrain abnormalities, neurodegeneration, and dysosteosclerosisLikely pathogenic
(Feb 21, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr5:149457800
GRCh38:
Chr5:150078237
CSF1RP202S, P54SBrain abnormalities, neurodegeneration, and dysosteosclerosisUncertain significance
(May 28, 2021)
criteria provided, single submitter
3.
GRCh37:
Chr5:149456988
GRCh38:
Chr5:150077425
CSF1RP247L, P99LBrain abnormalities, neurodegeneration, and dysosteosclerosisUncertain significance
(Oct 19, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr5:149440456
GRCh38:
Chr5:150060893
CSF1Rnot provided, Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1
Benign/Likely benign
(Apr 5, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr5:149457748
GRCh38:
Chr5:150078185
CSF1R, LOC111188154A219D, A71DBrain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1, not provided
Uncertain significance
(Nov 4, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr5:149439322
GRCh38:
Chr5:150059759
CSF1RQ543H, Q691Hnot provided, Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1
Conflicting interpretations of pathogenicity
(Oct 16, 2022)
criteria provided, conflicting interpretations
7.
GRCh37:
Chr5:149459797
GRCh38:
Chr5:150080234
CSF1RG137VBrain abnormalities, neurodegeneration, and dysosteosclerosis, Hereditary diffuse leukoencephalopathy with spheroidsUncertain significance
(Feb 23, 2021)
criteria provided, single submitter
8.
GRCh37:
Chr5:149449420
GRCh38:
Chr5:150069857
CSF1RBrain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1, not provided
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr5:149435759
GRCh38:
Chr5:150056196
CSF1Rnot provided, Brain abnormalities, neurodegeneration, and dysosteosclerosis, Hereditary diffuse leukoencephalopathy with spheroids
Benign
(Jul 30, 2021)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr5:149437190
GRCh38:
Chr5:150057627
CSF1RHereditary diffuse leukoencephalopathy with spheroids, Brain abnormalities, neurodegeneration, and dysosteosclerosis, not provided
Benign
(Jul 30, 2021)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr5:149447784
GRCh38:
Chr5:150068221
CSF1RY392*, Y540*Brain abnormalities, neurodegeneration, and dysosteosclerosisPathogenic
(May 5, 2020)
criteria provided, single submitter
12.
GRCh37:
Chr5:149441390
GRCh38:
Chr5:150061827
CSF1RW402*, W550*Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1Uncertain significance
(Oct 25, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr5:149435626
GRCh38:
Chr5:150056063
CSF1RW691C, W839CBrain abnormalities, neurodegeneration, and dysosteosclerosisUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr5:149459858
GRCh38:
Chr5:150080295
CSF1RV117MBrain abnormalities, neurodegeneration, and dysosteosclerosisUncertain significance
(Nov 4, 2019)
criteria provided, single submitter
15.
GRCh37:
Chr5:149449544
GRCh38:
Chr5:150069981
CSF1RV320L, V468Lnot provided, Brain abnormalities, neurodegeneration, and dysosteosclerosisUncertain significance
(Jun 5, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr5:149440465
GRCh38:
Chr5:150060902
CSF1RH643Q, H495Qnot providedUncertain significance
(Jun 7, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr5:149441159
GRCh38:
Chr5:150061596
CSF1RBrain abnormalities, neurodegeneration, and dysosteosclerosisPathogenic
(Jun 21, 2019)
no assertion criteria provided
18.
GRCh37:
Chr5:149440309-149440310
GRCh38:
Chr5:150060746-150060747
CSF1RBrain abnormalities, neurodegeneration, and dysosteosclerosisPathogenic
(Jun 21, 2019)
no assertion criteria provided
19.
GRCh37:
Chr5:149440654
GRCh38:
Chr5:150061091
CSF1Rnot specifiedUncertain significance
(Nov 22, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr5:149459812
GRCh38:
Chr5:150080249
CSF1RP132LBrain abnormalities, neurodegeneration, and dysosteosclerosisPathogenic
(Jun 21, 2019)
no assertion criteria provided
21.
GRCh37:
Chr5:149449505
GRCh38:
Chr5:150069942
CSF1RQ481*, Q333*Hereditary diffuse leukoencephalopathy with spheroids, not provided, Inborn genetic diseases
Pathogenic
(Aug 22, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr5:149440513-149440515
GRCh38:
Chr5:150060950-150060952
CSF1RK627del, K479delnot providedUncertain significance
(Sep 28, 2017)
criteria provided, single submitter
23.
GRCh37:
Chr5:149460553
GRCh38:
Chr5:150080990
CSF1RBrain abnormalities, neurodegeneration, and dysosteosclerosis, Hereditary diffuse leukoencephalopathy with spheroids, not provided
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr5:149460445
GRCh38:
Chr5:150080882
CSF1RBrain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1, not provided,
Hereditary diffuse leukoencephalopathy with spheroids
Benign
(Oct 19, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr5:149457678
GRCh38:
Chr5:150078115
CSF1R, LOC111188154Brain abnormalities, neurodegeneration, and dysosteosclerosis, not provided, Hereditary diffuse leukoencephalopathy with spheroids
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr5:149440465
GRCh38:
Chr5:150060902
CSF1Rnot provided, Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1,
Hereditary diffuse leukoencephalopathy with spheroids
Benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr5:149433597
GRCh38:
Chr5:150054034
CSF1RHereditary diffuse leukoencephalopathy with spheroids, Brain abnormalities, neurodegeneration, and dysosteosclerosis, not provided
Benign
(Jul 30, 2021)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr5:149433596
GRCh38:
Chr5:150054033
CSF1RBrain abnormalities, neurodegeneration, and dysosteosclerosis, not provided, Hereditary diffuse leukoencephalopathy with spheroids
Benign
(Jul 30, 2021)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr5:149435879
GRCh38:
Chr5:150056316
CSF1RR782H, R634HBrain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1, not provided,
Hereditary diffuse leukoencephalopathy with spheroids
Pathogenic/Likely pathogenic
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination